Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-02-002175
Filing Date
2002-03-11
Accepted
2002-03-11 00:00:00
Documents
8
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 AAIPHARMA INC. g74549e10-k.txt 10-K 355181
3 FIRST AMENDMENT TO SECOND AMENDED LOAN AGREEMENT g74549ex10-19.txt EX-10.19 48485
4 SECOND AMENDMENT TO SECOND AMENDED LOAN AGREEMENT g74549ex10-20.txt EX-10.20 21345
5 AMENDMENT NO. 3 TO PARTICIPATION AGREEMENT g74549ex10-21.txt EX-10.21 29664
6 SUBSCRIPTION AGREEMENT DATED 10-19-01 g74549ex10-22.txt EX-10.22 16462
7 PRODUCT SALES AGREEMENT DATED 12-21-01 g74549ex10-23.txt EX-10.23 52960
8 CONSENT OF INDEPENDENT AUDITORS g74549ex23.txt EX-23 692
9 ADDITIONAL RISK FACTORS g74549ex99-2.txt EX-99.2 46988
  Complete submission text file 0000950144-02-002175.txt   574338
Mailing Address 2320 SCIENTIFIC PARK DRIVE WILMINGTON NC 28405
Business Address 2320 SCIENTIFIC PARK DRIVE WILMINGTON NC 28405 9102547000
AAIPHARMA INC (Filer) CIK: 0001013243 (see all company filings)

EIN.: 042687849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21185 | Film No.: 02572034
SIC: 8734 Services-Testing Laboratories